Back to search

Article

Statin Use and Genetically Predicted HMG-CoA Reductase Inhibition in Relation to Clonal Hematopoiesis

2026-07-13

Abstract excerpt

<h4>Background</h4> Clonal hematopoiesis (CH) is associated with increased risks of diverse cardiovascular diseases, hematologic malignancies and mortality, yet no preventive therapies are approved. As emerging data implicate lipid pathways in CH pathogenesis, we investigated the association of statin use and genetically proxied inhibition of HMG-CoA reductase (HMGCR) with CH risk, and validated findings using pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
18d75ecb-c940-5d31-bce1-6cb935f5705c
DOI
10.64898/2026.07.08.26357595
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Statin Use and Genetically Predicted HMG-CoA Reductase Inhibition in Relation to Clonal HematopoiesisDOI 10.64898/2026.07.08.26357595
Select a neighboring publication to make it the new centre.